IMMUNIO
IMMUNIO secures your web applications against all attackers. It is the easiest, most effective method to ensure that you are alerted when important security events are triggered, and that threats are dealt proactively.
IMMUNIO
Industry:
Cyber Security Network Security Security
Founded:
2013-10-24
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.immun.io
Total Employee:
11+
Status:
Closed
Contact:
(888) 575-9189
Email Addresses:
[email protected]
Total Funding:
7.7 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Cloudflare Hosting Cloudflare SSL Amazon Virginia Region Product Schema New Relic Microdata For Google Shopping Google Identity Platform Amazon Oregon Region
Current Advisors List
Current Employees Featured
Founder
Investors List
BDC Venture Capital
BDC Venture Capital investment in Series A - IMMUNIO
Bloomberg Beta
Bloomberg Beta investment in Series A - IMMUNIO
Real Ventures
Real Ventures investment in Series A - IMMUNIO
Hoxton Ventures
Hoxton Ventures investment in Series A - IMMUNIO
White Star Capital
White Star Capital investment in Series A - IMMUNIO
Real Ventures
Real Ventures investment in Seed Round - IMMUNIO
Bloomberg Beta
Bloomberg Beta investment in Seed Round - IMMUNIO
BDC Venture Capital
BDC Venture Capital investment in Seed Round - IMMUNIO
Hoxton Ventures
Hoxton Ventures investment in Seed Round - IMMUNIO
Newest Events participated
Participated in AWS re:Invent
on 2021-01-12 as sponsor
Participated in APPSEC USA 2017
on 2017-09-19 as sponsor
Participated in AGC 13th Annual West Coast Technology Conference
on 2017-02-13 as exhibitor
Participated in Pycon 2016
on 2016-05-28 as sponsor
Participated in FutureStack 15
on 2015-11-11 as sponsor
More informations about "IMMUNIO" on Search Engine
IMMUNIO - Crunchbase Company Profile & Funding
Founded Date Oct 24, 2013. Founders Mike Milner, Oliver Lavery, Zaid Al Hamami. Operating Status Closed. Last Funding Type Series A. Legal Name IMMUNIO Inc. …See details»
Trend Micro Acquires Immunio and Expands Hybrid Cloud …
IMMUNIO is a pioneer in real-time web application security (RASP), providing automatic detection and protection against application security vulnerabilities. The company’s …See details»
Montreal-based Immunio acquired by Trend Micro
Nov 29, 2017 I mmun.io, a real-time web application security system (RASP), announced that it was acquired by Trend Micro, a cybersecurity …See details»
Trend Micro Acquires Immunio and Expands Hybrid Cloud …
Nov 28, 2017 New capabilities, attained through a combination of acquiring Montréal, Canada-based Immunio and in-house development, increase the automated protection …See details»
Immunio’s App-Security Tool for Secure Development
Application security startup Immunio has announced general availability of its application-security-as-a-service solution, designed to detect and thwart attacks in real time. Gartner originally dubbed this market segment …See details»
Immunio Raises $5 Million to Protect Web Applications
Based in Montreal, Immunio technology allows companies to release software into production efficiently, knowing that applications will be “immune” to exploitation. “We are …See details»
Immunio | BDC.ca
Quebec. Industry sector. Information technology. Investment year. 2015. Fund. IT Venture Fund. Learn more. Lead. Steven Abrams. Partner. View profile. About the company. …See details»
Immunio Company Profile - Craft
Immunio is a company that specializes in real-time web application security. It offers a runtime application self-protection (RASP) solution providing automatic detection and …See details»
IMMUNIO - Contacts, Employees, Board Members, Advisors
About. IMMUNIO has 2 current employee profiles, including Investor Amol Sarva. IMMUNIO has 4 board members and advisors, including Jean-Sebastian Cournoyer. Contacts. …See details»
IMMUNIO - Funding, Financials, Valuation & Investors - Crunchbase
Lead Investors 1. Investors 6. Funding. IMMUNIO has raised a total of. $7.7M. in funding over 2 rounds. Their latest funding was raised on Apr 27, 2016 from a Series A round. …See details»
Cancer Research Institute | Advancing Immunotherapy Research
Cancer Research Institute | Advancing Immunotherapy Research. For a World Immune to Cancer. We established immunotherapy as the fourth pillar in treating cancer for one …See details»
ImmUnity Canada - Primary Immunodeficiency Society
ImmUnity Canada - Primary Immunodeficiency Society. Formerly the Canadian Immunodeficiencies Patient Organization. Empowering people with primary …See details»
About ImmUnity Canada - Primary Immunodeficiency Society
ImmUnity Canada is a not-for-profit charitable organization that provides a community for people and families impacted by primary immunodeficiency. We advocate for education, …See details»
Advice on the use of point-of-care immunodiagnostic tests for …
Scientific Brief. 8 April 2020. Since this brief was published, WHO has updated its advice and released guidance on the use of antigen detection rapid diagnostic tests. Please …See details»
Trend Micro Acquires Immunio and Expands Hybrid Cloud …
Nov 27, 2017 IMMUNIO is a pioneer in real-time web application security (RASP), providing automatic detection and protection against application security vulnerabilities. …See details»
Datadog teams with IMMUNIO for real-time app security threat …
Jul 27, 2016 IMMUNIO provides real-time detection and defense against attacks for your web applications. For most popular web frameworks, IMMUNIO installs in two minutes, …See details»
What Is Immunotherapy? | Cancer Research Institute
Cancer immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control, and eliminate cancer.See details»
Canadian Immunodeficiencies Patient Organization - National ...
The Canadian Immunodeficiencies Patient Organization (CIPO) is a national, non-profit organization for individuals with primary immunodeficiencies (PIDs) and their families. It …See details»
First-in-class clinical assets in immuno-oncology and immuno ...
6 days ago A clinical-stage biotechnology company in Immuno-Oncology and Immuno-Inflammation Focused on developing and partnering therapies to control the immune …See details»
Immunodeficiency Canada Network
Welcome to Immunodeficiency Canada Network, your hub for empowerment and resilience in the face of immunodeficiency challenges. We are a dedicated community …See details»